Pre-Test 62002-endp

In the absence of existing data for hepatitis C prevalence, healthcare providers should initiate universal hepatitis C screening until they establish that the prevalence of HCV RNA positivity in their population is 0%.

Some of the (medication-assisted treatment) for OUD work on the opioid-mu receptor

New Jersey Opioid Data Dashboard uses static data visualizations to display opioid and other drug-related indicators